Praneetha Thulasi, MD
Assistant Professor
Section of Cataract, Cornea, External Diseases
Emory Eye Center
Atlanta, GA

It is the policy of Creative Educational Concepts, LLC, (CEC) to ensure independence, balance, objectivity, and scientific rigor and integrity in all their CME/CE activities. Activity planners, faculty, peer reviewers, and CEC staff must disclose to the participants any relationships with ineligible entities whose products or devices may be mentioned in this CE activity, or with the commercial supporter of this CE activity. An ineligible entity is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Financial relationships may include research grants, consultant fees, travel, advisory boards, consultancy, speakers’ bureaus, other benefits, or having a self-managed equity interest in a company.

CEC has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Planners:
Candice Gillett, MPH–has no relevant financial relationships to disclose in relation to the content of this activity.
Susan Yarborough, CHCP–has no relevant financial relationships to disclose in relation to the content of this activity.

Faculty:
Praneetha Thulasi, MD–has no relevant financial relationships to disclose in relation to the content of this activity.

Peer Reviewer:
Scott J. Hershman, MD, FACEHP, CHCP–has no relevant financial relationships to disclose in relation to the content of this activity.
Paul Karpecki, OD, FAAO–has disclosed that he is an advisor or consultant to Alcon, Aldeyra, Allergan/Abbvie, Ametek, Atlas Medical, Avellino Labs, Azura, Bausch + Lomb, BioTissue, Blephex, Bruno Pharmaceuticals, Cambium, Dompe, GoBiquity, Haag Streit, Hilco, iCare USA, Imprimis, Johnson & Johnson Vision, Kala Pharmaceuticals, KEPLR Vision, Kiora Pharmaceuticals, Konan Medical, LenTechs, Neurolens, Novartis, Oasis Medical, Oculus, OcuSoft, Optase, Oyster Point Medical, Rendia, RVL Pharmaceuticals, RxSight, Science Based Health, Sentiss Pharmaceuticals, Sight Sciences, Sun Pharmaceuticals, Surface Pharmaceuticals, Tarsus Medical, Thea, Visant Medical/Stepwise, and Vital Tears. He is also on the speakers bureau for Mallinckrodt and has stock options in Silk Technologies and SleepTite.

CEC Staff/Planners:
Susan H. Gitzinger, PharmD, MPA–has no relevant financial relationships to disclose in relation to the content of this activity.
Ashley C. Lilly, MHA–has no relevant financial relationships to disclose in relation to the content of this activity.

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CEC, the faculty, and any commercial supporter of this activity do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.